Peptide record

TPDB05628

Antibacterial Toxicity standard
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05628
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 8-aa standard-residue multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
WKSYVRRW
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C57H81N17O11
ANDCEQGHILMFPT
RW
1180.38
11.39
3
0
4
+3
3.78
-1.575
36.25
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
12490
10.58
2
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
1
K
0
M
0
F
0
P
1
S
0
T
2
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 1 M: 0 F: 0 P: 0 S: 1 T: 0 W: 2 Y: 1 V: 1
Chemical Descriptors
8 reviewed residue count
C57H81N17O11 sequence-only estimate (linear, free termini)
1180.38 sequence-only estimate (linear, free termini)
11.39 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
3.78 sequence-only estimate (linear, free termini)
-1.575 sequence-only estimate (linear, free termini)
Evidence Records 2 records
Evidence 1 Activity

Activity

2% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
2% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. | Bioorg Med Chem Lett | 2013
Evidence 2 Activity

Activity

% Hemolysis
Toxicity
0.3 %
Hemolytic
Hemolytic_activity: [Ref.23570790]2.0±0.3% hemolysis at 100µM against human red blood cells.

Target

erythrocytes

Source & Reference

NA
DRAMP
Bioorg Med Chem Lett. 2013 May 15 23(10):2929-32.